Revance Therapeutics, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Revance Therapeutics, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2011 to Q4 2023.
  • Revance Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $12.9M, a 32.8% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $12.9M +$3.19M +32.8% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $9.71M +$1.96M +25.2% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $7.75M +$588K +8.21% Dec 31, 2021 10-K 2024-02-28
Q4 2020 $7.17M +$1.47M +25.8% Dec 31, 2020 10-K 2024-02-28
Q4 2019 $5.7M +$1.5M +35.7% Dec 31, 2019 10-K 2023-02-28
Q4 2018 $4.2M +$1.62M +63% Dec 31, 2018 10-K 2022-02-28
Q4 2017 $2.58M +$758K +41.7% Dec 31, 2017 10-K 2021-02-25
Q4 2016 $1.82M +$282K +18.3% Dec 31, 2016 10-K 2020-02-26
Q4 2015 $1.54M +$269K +21.2% Dec 31, 2015 10-K 2019-02-28
Q4 2014 $1.27M -$1.02M -44.6% Dec 31, 2014 10-K 2018-03-02
Q4 2013 $2.29M +$276K +13.7% Dec 31, 2013 10-K 2017-02-28
Q4 2012 $2.01M +$100K +5.23% Dec 31, 2012 10-K 2016-03-04
Q4 2011 $1.91M Dec 31, 2011 10-K 2015-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.